US 10022367
Sustained-release buprenorphine solutions
granted A61KA61K31/485A61K47/10
Quick answer
US patent 10022367 (Sustained-release buprenorphine solutions) held by Indivior UK Limited expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Indivior UK Limited
- Grant date
- Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 49
- CPC classes
- A61K, A61K31/485, A61K47/10, A61K47/22, A61K9/0019